News About: Pharm. Industry
Drug advertisement layouts decline last year
The number of drug ads layouts last year totaled 932 cases, down 77 cases from the previous year, according to the Korea Pharmaceutical Manufacturers Association.
The association said the declining trend for drug a...
Salespersons challenge anti-rebate action
A dispute has arisen over more strengthened anti-rebate actions imposed by pharmaceutical firms.
Salespersons in small- and medium-sized pharmaceutical firms are striving to provide more generous kickbacks on medic...
FTC officials raid pharmaceutical firms in rebate probe
A team of officials from the Fair Trade Commission (FTC) raided the headquarters of CJ Jeildang and Janssen Korea on January 12 and 13, respectively, as part of a widening investigation into kickback allegations again...
KPMA launches drug technology research group
The Korea Pharmaceutical Manufacturers Association said it has launched a new drug technology research group to beef up efforts to develop new pharmaceutical technologies through a closer collaboration between industr...
Drug manager to receive mandatory training
The government plan to run mandatory basic training to improve the capacity of managers involved in the manufacture and import of medicines, possibly in the first half of this year.
A bill to have managers in produ...
Schenell Biopharmaceutical jumps into biosimilars
Schenell Biopharmaceutical Inc. is jumping into a blue ocean for newer versions of innovator biopharmaceutical products, biosimilars, following an agreement with Aprogen Co. to take over all marketing rights of biosim...
Promotion elevates morale of OTC managers
This year’s executive promotion announcement at major pharmaceutical firms has enhanced the morale of OTC personnel.
A number of OTC managers have promoted to executives at Dong-A Pharm, Chong Kun Dang Pharmceutica...
Bukwang starts shipping first local hepatitis B drug
Bukwang Pharm says it will send to the Philippines the first ship loaded with 6,600 packs (30 mg x 30 caps) of Levovir capsule, the first domestically developed treatment for the disease and the 11th original Korean d...
Safety of Lanzhou botulinum toxin proven for 8 years
Botulinum toxin manufactured by China’s Lanzhou Institute of Biological Products has not been associated with deaths for the last eight years, according to Hanall Pharm.
The company claimed that no death has been r...
Health insurance to screen eligibility of 1,880 OTCs
The government will evaluate the economic effectiveness of 1,880 OTC products from March to exclude items that are the least cost-effective from the second half of this yeasr, the Ministry of Health, Welfare and Famil...
